Eculizumab (Anti-Complement C5)

製品コードA2538 別名: Anti-Human C5, Humanized Antibody

製品コード：A2538 純度：99%

Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research. MW: 145.5 KD.

サイズ	価格(税別)	在庫状況
1mg	JPY 87000	国内在庫あり
1mg*5	JPY 248300	お問い合わせ
1mg*25	JPY 735000	お問い合わせ

代表番号: 045-509-1970\|電子メール：[email protected] よく尋ねられる質問

質量管理及び製品安全説明書

現在のバッチを見る： A253801 純度： 99% タンパク質濃度： 11.6mg/ml 内毒素：＜1EU/mg

生物活性

製品説明	Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research. MW: 145.5 KD.

製品説明

CAS No.	219685-50-4
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype	Human IgG1
Source	CHO
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping	Shipped under low temperature conditions
Sterility	11.6mg/ml

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須